Image Ben Hargreaves Digital Digital health: the new normal? Personalised and tailored healthcare that utilises patient’s data is rapidly becoming a reality. Views & Analysis The power of self-management to target gaps in chronic disea... The time of healthcare professionals is limited, but systems often rely on them as the principal means to help patients with chronic diseases. Views & Analysis GSK continues campaign for greater adult immunisation covera... The UK company reveals the results from a partner-led survey to discover the rates of vaccination for adults, why levels are lower than expected, and what can be done to improve this. Views & Analysis Osteoporosis treatment options - down to the bare bones It is World Osteoporosis Day this month, and Ben Hargreaves takes a look at what treatment options look like for patients living with the disease. Load more results
Digital Digital health: the new normal? Personalised and tailored healthcare that utilises patient’s data is rapidly becoming a reality.
Views & Analysis The power of self-management to target gaps in chronic disea... The time of healthcare professionals is limited, but systems often rely on them as the principal means to help patients with chronic diseases.
Views & Analysis GSK continues campaign for greater adult immunisation covera... The UK company reveals the results from a partner-led survey to discover the rates of vaccination for adults, why levels are lower than expected, and what can be done to improve this.
Views & Analysis Osteoporosis treatment options - down to the bare bones It is World Osteoporosis Day this month, and Ben Hargreaves takes a look at what treatment options look like for patients living with the disease.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
